🌟New #Research: #Clinicohematological profile and immunophenotypic patterns of childhood acute #leukemia: Prognostic correlation By Anju Khairwa et al. Read it here #OpenAccess: doi.org/10.36922/td.25…

🌟New #Research: #Columella fistula: A case report By Sara Moujrid et al. Read it here #OpenAccess: doi.org/10.36922/td.25…

🧐We welcome you to read "Pyogenic #granuloma of maxillary median #gingiva in a pediatric patient: A case report and literature review" By Takeshi Karube et al. Full text: doi.org/10.36922/td.22…

🌟New #Research: Investigating long noncoding #RNA HA117 and its possible regulatory network in #osteosarcoma 👥By Ning Wang et al. Read it here #OpenAccess: doi.org/10.36922/td.36…

📢New Special Issue Open: "Role of Viruses in #Tumorigenesis" warmly welcoming new submissions. ✏️Guest editor: Prof. Pier Paolo Piccaluga, Prof. Davide Gibellini & Prof. Marianne Wanjiru Mureithi 🔗accscience.com/journal/TD/spe…

📬📬New Special Issue Open: "Circulating Tumor Cells: The "Seeds" of #Cancer Metastasis" warmly welcoming new submissions. ✏️✏️Guest Editor: Dr. Mohamed Kamal accscience.com/journal/TD/spe…

🎉Exciting news from Tumor Discovery! 🚀New Release: Volume 3 Issue 3 is now online. 👉accscience.com/journal/TD/3/3 #OpenAccess #CancerResearch #Tumor

📢📢Call for papers: "Advances in #Tumor #Immune Regulation: Mechanisms and Therapeutic Insights" 👉👉Guest Editor: Prof. Mingzhu Yin accscience.com/journal/TD/spe…

Recently, the 2024 #Clarivate Highly Cited Researchers list has been revealed. We are proud to note that this list includes Prof. Mohammad Amjad Kamal, the Editorial Board Member of Tumor Discovery. Please join us in congratulations🥳🥳🥳

Read our latest: EpCAM-targeting #cancer #immunotherapies: Evidence from clinical studies and the way forward. From Stefan Barth et, al. accscience.com/journal/TD/art…

📢Recommended Paper: Expert consensus and current landscape of #NUTcarcinoma: A comprehensive strategy from diagnosis to treatment By: Mingzhu Yin et al. Free Access:👇👇 accscience.com/journal/TD/art…

🥳🥳Season's greetings from all of us at Tumor Discovery! Wishing you a Happy New Year！

🌲On our December cover!🌲 This study by Yin et al. sheds new light on #NUTcarcinoma and provides more precise and standardized #diagnostic and #therapeutic #guidelines for clinicians. accscience.com/journal/TD/3/4…

🎉 Welcome to the latest issue from Tumor Discovery! ✨ New Release: Volume 3 Issue 4 is now online. 👉 accscience.com/journal/TD/3/4 #OpenAccess #InterestingPaper #CancerResearch #Tumor

👉Call for papers: Advanced Interdisciplinary Approaches to #Cancer #Diagnosis, #Treatment, and Management ✨SI website: accscience.com/journal/TD/spe… 🥳It is linked to the upcoming Conference: "tise.iul.ac.in/About-Us.aspx"

🥳Recommended Paper: Homoharringtonine inhibits #PancreaticCancer progression via #mitochondrial energy metabolism suppression and #macrophages reduction By: Haiyan Xu et al. Free Access:👇👇 accscience.com/journal/TD/art…

🥳🥳Welcome to read the latest issue! 👉Link: accscience.com/journal/TD/4/1 Topic: #immunotherapy #breastcancer #tumorigenesis #ColorectalCancer #pancreaticcancer #OpenAccess #InterestingPaper #CancerResearch #Tumor

👉Read our latest: Exploring the #cell-to-cell communication network to better defeat #cancer From Chen Yeh, Thierry Madison, and Krushna Plas. Link: accscience.com/journal/TD/art…

🥳Latest Review: #cancer FBXW7 in leukemia: A critical regulator of oncogenic stability and a potential therapeutic target ✍️By: Xiuming Li, Bin Liu 👀Link: api-journal.accscience.com/journal/articl…

🥳🥳🥳: The latest article has been published #CancerResearch #Cancers 👀Here: accscience.com/journal/TD/4/2 🤗Topics Included: AI in cancer research, melanoma, glioblastoma, hepatocellular carcinoma, colorectal cancer, Drug treatment, etc. 📑Welcome to discuss with us!